Clinical Trial Consultants

What Clinical Trial Consultants does

Clinical Trial Consultants (CTC), the wholly-owned CRO subsidiary of Center for Translational Research Sweden AB (CTR), was founded in 2011 in Uppsala and operates an in-house site network of 6 clinical research clinics across Sweden (Uppsala, Stockholm, Linköping, Gothenburg) plus one in Groningen, Netherlands (established February 2024). The company provides full-service contract research organization (CRO) capabilities covering Phase 0, First-in-Human (FIH), Phase I, and Phase II clinical trials, as well as medical device investigations, with a stated track record of 500+ clinical trials, 6-8 FIH studies annually, ~4,000 in-patient stays, ~10,000 out-patient visits, and ~500,000 blood samples processed per year across 60+ beds.

CTC's service portfolio is built around the in-house site network and an integrated stack of service modules: Project Management, Clinical Monitoring (CRA), Medical Writing, DMPK & Clinical Pharmacology, Biometrics (with Pinnacle 21 Enterprise for CDISC SDTM/ADaM/SEND compliance), and pre- and post-market Pharmacovigilance. Specialized techniques include Expert Precision QT (EPQT) cardiac safety assessment and decentralized/virtual trial capabilities operating under the ClinSmart Concept (integrated in 2022). The company differentiates by vertical integration, controlling execution at the site rather than outsourcing investigator relationships, and by bundling regulatory, toxicology (via sister company TKT), bioanalysis (Lablytica), and regulatory affairs (RegSmart) services through the parent CTR group.

CTC generates revenue on a project-based professional services model, with quote-based pricing delivered through RFPs managed by a dedicated Customer Relations team; contracts are typically multi-year and include end-to-end trial conduct plus modular service additions. Customer segments are pharmaceutical and biotech companies (with the majority of named logos being small-cap biotechs: AlzeCure Pharma, ArkBio, EpiEndo, Asarina Pharma, Empros Pharma, Neurolixis, Dicot Pharma) plus medtech for device investigations. Distribution is enterprise sales-led, supported by conference presence (NLSDays, SwedenBIO), LinkedIn, scientific publications, and a co-produced podcast (CTR Podcast "Idé till patient").

Name

Clinical Trial Consultants

Legal name

CTC Clinical Trial Consultants AB

Website

https://ctc-ab.se

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

Clinical Trial Consultants is a Swedish full-service CRO with an in-house network of 7 clinical research clinics (6 in Sweden, 1 in the Netherlands) providing Phase 0 to Phase II trials and medical device investigations for pharmaceutical and biotech companies.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL), Clinical Trial Management Systems (CTMS) (HLACAOAD), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)

Keywords

• Clinical trial services
• Contract research organization
• First-in-human studies
• Pharmacovigilance services
• Biometrics services

Headquarters

HQ city

Uppsala

HQ country

Sweden

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Trial Services: Full-service CRO providing clinical trial management and conduct services from Phase 0 through Phase II studies and medical device investigations. Revenue generated through project-based fees for study design, conduct, monitoring, data management, biometrics, pharmacovigilance, and medical writing services.
2. Site Network Services: In-house clinical research unit services including First-in-Human studies, patient studies, and outpatient visits conducted at their 7 clinic locations across Sweden and Netherlands.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Clinical Trial Consultants (CTC) is a Swedish full-service Contract Research Organization providing end-to-end management and conduct of Phase 0, First-in-Human (FIH), Phase I, and Phase II clinical trials, as well as medical device investigations. The company operates an in-house Site Network of 7 state-of-the-art research clinics across Sweden and the Netherlands, and offers in-house departments for clinical monitoring, medical writing, project management, DMPK and clinical pharmacology, biometrics, and pharmacovigilance. The ClinSmart Concept provides standardized virtual and digital processes connecting all sites across the network.

Product overview

CTC (Clinical Trial Consultants) is a Swedish full-service Contract Research Organization (CRO) founded in 2011, providing comprehensive clinical trial services from Phase 0 through Phase II and medical device investigations. CTC's distinctive platform is built on an in-house Site Network of 6 state-of-the-art research clinics across Sweden (Uppsala, Stockholm, Linköping, Gothenburg) plus an additional clinic in the Netherlands, enabling full-service conduct without reliance on third-party investigator sites. The service portfolio centers on this Site Network combined with in-house departments for Clinical Monitoring (CRA), Medical Writing, Project Management, DMPK & Clinical Pharmacology, Biometrics (including Pinnacle 21 Enterprise for CDISC compliance), Pharmacovigilance, and Advisory/Concepts services. The ClinSmart Concept provides a standardized virtual and digital overlay connecting all sites. The company operates as part of the Center for Translational Research (CTR) group, which includes sister companies for regulatory, toxicology, bioanalysis, and other specialized services. Key differentiators include an FIH unit at Uppsala University Hospital, 60+ beds across the site network, and specialized techniques such as EPQT and decentralized trial capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• ClinSmart Concept: A modern concept connecting all CTC sites through common routines, virtual/digital tools, and processes for conducting effective clinical trials.
• Advisory Team

Products and services

• Full-Service CRO Capabilities (Phase 0 to Phase II) End-to-end full-service Contract Research Organization services spanning Phase 0, First-in-Human, Phase I, and Phase II clinical trials for pharmaceutical, biotech, and medtech sponsors. Includes protocol development, study conduct, monitoring, data management, biometrics, medical writing, and final reporting.
• CTC Site Network In-house network of 6 state-of-the-art research clinics across Sweden (CTC Sjukhuskliniken, CTC MTC, CTC Oscar in Uppsala; CTC Stockholm; CTC Ebbepark, Linköping; CTC GoCo, Gothenburg) and one in the Netherlands (CTC Netherlands, Groningen). 60+ beds, enabling direct access to healthy volunteers and patient populations for First-in-Human, Phase I-IV, and medical device studies.
• Biometrics Services Comprehensive biometrics suite covering Biostatistics, eCRF and Data Management, and Statistical Programming, using Pinnacle 21 Enterprise for CDISC data validation to support FDA, PMDA, and NMPA submissions for clinical studies.
• Pharmacovigilance Services In-house pharmacovigilance services covering pre- and post-market drug safety surveillance: Clinical Coding, Medical Monitoring, Safety Committees, Safety Management Plans, and safety reporting. Includes independent in-house medical monitoring from First-in-Human studies through market.
• DMPK and Clinical Pharmacology Services DMPK and Clinical Pharmacology services spanning non-clinical DMPK in lead optimization and preclinical development through Clinical Pharmacology from First-in-Human through proof-of-concept trials, including pharmacokinetic and pharmacodynamic analysis.
• Medical Writing Services Professional medical writing services including protocol development, clinical study reports, and regulatory documentation, coordinated as part of full-service project delivery.
• Clinical Trial Project Management Dedicated clinical research managers guiding sponsors through the entire clinical trial process, coordinating internal activities and ensuring compliance with guidelines and regulations.
• Clinical Monitoring (CRA Services) In-house Clinical Research Associate (CRA) team providing quality control and monitoring of clinical trials, serving as the primary contact between the clinic and sponsor and ensuring compliance with regulations, GCP, and study protocols.
• Concepts (Scientific & Medical Advisory Services) Tailor-made scientific and medical advisory services for optimized trial design from First-in-Human through Phase II and beyond, via a core advisory team including founders and senior advisors in clinical pharmacology, DMPK, and early phase development.
• Subject Recruitment Services Specialized recruitment services for healthy volunteers and patient populations, maintained via a database (CQ) of nearly 8,000 potential participants and a dedicated recruitment team.
• Medical Device Investigations Dedicated services for medical device clinical investigations, including start-up support, clinical conduct, and monitoring, aligned with ISO 14155 and applicable regulatory requirements for device sponsors.
• CTC Netherlands Clinical Research Unit Clinical research unit (CTC Netherlands BV) in Groningen, Netherlands, on the University Medical Center Groningen (UMCG) campus. 12 beds; specializes in early phase patient research and healthy volunteer studies requiring invasive procedures. First CTR-group company established outside Sweden.
• Special Techniques Innovative methodologies for smart trial design addressing complex endpoints, including Expert Precision QT (EPQT) cardiac safety assessment (CTC is a certified ERT site), decentralized/virtual trial capabilities, and collaboration with Immuneed for in-vitro immunological risk assessment.

Quantifiable outcome

• 500+ clinical trials conducted with 500+ clinical trials completed
• +3 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• OptiCell SolutionscoreStrategic or Co-development Partner · 25 June 2025Strategic collaboration for Cell and Gene Therapy (CGT) projects. OptiCell provides advanced apheresis solutions for collecting specific target blood cells while CTC offers comprehensive clinical trial support from planning through regulatory management and clinical conduct.
• CTC Netherlands BVcoreStrategic or Co-development Partner · 29 February 2024CTR established first international company in Groningen, Netherlands. Operates 12-bed clinical research unit at UMCG campus, specializing in early phase patient research. Founders bring 60+ years of clinical pharmacology experience.
• UnilabscoreStrategic or Co-development Partner · 23 February 2024Diagnostics partnership enabling CTC to access hospital-based services including MRI and CT scans in Stockholm, Uppsala, Gothenburg, and Malmö for clinical trials requiring advanced medical technology.
• A+ Science ABcoreStrategic or Co-development Partner · 10 October 2023CTR acquired A+ Science, integrating operations into CTC. Expands pharmacovigilance services portfolio and international presence. A+ brings 26 years of experience and network across Nordics and Europe.
• ClinSmart SwedencoreStrategic or Co-development Partner · 1 January 2022Merged ClinSmart into CTC, bringing virtual trial infrastructure and late-phase clinical trial capabilities. ClinSmart concept for virtual studies and digital tools now integrated across all CTC sites.
• NBMI Science LimitedminorStrategic or Co-development Partner · 1 March 2020Virtual pilot study for mercury intoxication treatment. Supported by Vinnova funding and Medical Products Agency. Used electronic consent, remote video visits, and home-based blood collection.
• RegSmart Life Science ABcoreStrategic or Co-development PartnerSister company within CTR group providing regulatory affairs services. Core advisory team can supplement meetings with RegSmart experts for regulatory strategy.
• Toxicology Knowledge Team (TKT)coreStrategic or Co-development PartnerSister company within CTR group acquired in 2021. Provides toxicological support with 7 PhD toxicologists, one of largest in Nordic countries.
• Lablytica Life Science ABcoreStrategic or Co-development PartnerSister company within CTR group providing DMPK/bioanalysis services. Analyzed concentrations in plasma, urine, and CSF for AlzeCure studies.
• MetaSafe ABminorStrategic or Co-development PartnerSister company within CTR group providing MIST (Metabolite in Safety Testing) analysis and metabolite profiling services.
• Center for Translational Research (CTR)coreOthersCTR is the holding company founded in 2016, encompassing CTC and multiple sister companies in translational research services. Karin Meyer serves as CEO of CTR.

Scale indicators8 records

Recent moves11 records

Expansion highlights5 records

Direct peers

• Celerion: Celerion is a global early-phase CRO specializing in First-in-Human, Phase I/IIa studies, and clinical pharmacology — directly comparable to CTC's core FIH/Phase I-II focus. Both operate dedicated clinical research units with healthy volunteer and patient capabilities, competing for similar biotech and pharma sponsors in early clinical development.
• Quotient Sciences: Quotient Sciences is a UK-based CRO with an integrated drug development platform spanning formulation, manufacturing, and early-phase clinical trials with in-house clinical units. Like CTC, it focuses on early-phase (FIH/Phase I) and offers translational services, competing for the same biotech sponsors seeking integrated early-development partners.
• Frontage Laboratories: Frontage is a US-based CRO with strong early-phase clinical and bioanalytical capabilities, including clinical research units. Comparable to CTC in offering integrated CMC, DMPK, biometrics, and clinical trial services for early-phase drug development across small and mid-sized biotech.
• SGS Health & Nutrition (SGS Clinical Research): SGS operates an early-phase clinical research business with clinical pharmacology units across Europe (Belgium, Hungary, Germany). Direct competitor to CTC in European Phase I/FIH trials for pharma and biotech sponsors, with overlapping geographic coverage in continental Europe.
• WCCT Global (Worldwide Clinical Trials Early Phase): WCCT Global is an early-phase CRO with multiple clinical research units focused on FIH and Phase I/II studies, particularly in specialized populations. Competes with CTC for biotech sponsors requiring FIH expertise and complex early-phase trial design.

Broad incumbents

• ICON plc: ICON is one of the world's largest CROs offering full-service Phase I-IV capabilities, including early-phase units (formerly PRA Health Sciences). Competes with CTC for larger pharma early-phase contracts and preferred-vendor relationships, but at significantly greater scale and global reach.
• PAREXEL International: PAREXEL is a global full-service CRO with broad Phase I-IV capabilities and significant early-phase expertise (including early-phase clinical pharmacology units). Competes with CTC for enterprise pharma early-phase work, though at much larger scale and with global preferred-vendor arrangements.
• IQVIA: IQVIA is the world's largest CRO and life sciences services provider, offering full Phase I-IV services with extensive early-phase capabilities. Serves as the dominant incumbent against which CTC competes for major pharma early-phase business; the scale differential is substantial.
• Charles River Laboratories: Charles River offers integrated early-phase CRO services alongside its discovery and safety assessment business, including clinical pharmacology units. Comparable to CTC's preclinical-to-Phase I value chain (especially given CTR's TKT toxicology acquisition), but at much larger global scale.
• Medpace: Medpace is a mid-to-large full-service CRO with strong Phase I-IV capabilities and growing early-phase presence. While not primarily FIH-focused like CTC, it competes for the same biotech and mid-pharma sponsors seeking integrated clinical development services with a more personalized operating model than mega-CROs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ctc-clinical-trial-consultants-ab
• Xx.com/ctc_ab
• Facebookfacebook.com/clinicaltrialconsultants

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Trial Consultants